Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio (2009 - 2026)

Teva Pharmaceutical Industries (TEVA) has reported Asset Utilization Ratio for 18 consecutive years, with 0.43 the latest figure, recorded in Q1 2026.

• Quarterly Asset Utilization Ratio rose 9.21% year-over-year to 0.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.43 (up 9.21% YoY) and the FY2025 annual result came in at 0.43, up 7.87% from the prior year.
• Asset Utilization Ratio held at 0.43 in Q1 2026 per TEVA's latest filing, from 0.43 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for TEVA reached as high as 0.43 in Q1 2026 and fell as low as 0.33 in Q1 2022.
• A 5-year average of 0.37 and a median of 0.37 in 2024 frame the typical range for Asset Utilization Ratio.
• The largest YoY upside for Asset Utilization Ratio was 14.1% in 2025 against a maximum downside of 4.32% in 2025.
• Year by year, Asset Utilization Ratio stood at 0.34 in 2022, then increased by 9.5% to 0.37 in 2023, then rose by 1.33% to 0.38 in 2024, then rose by 14.1% to 0.43 in 2025, then rose by 0.3% to 0.43 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.43, 0.43, and 0.39 for Q1 2026, Q4 2025, and Q3 2025 respectively.